0001567619-20-006578.txt : 20200317
0001567619-20-006578.hdr.sgml : 20200317
20200317162451
ACCESSION NUMBER: 0001567619-20-006578
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200317
DATE AS OF CHANGE: 20200317
EFFECTIVENESS DATE: 20200317
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gracili Therapeutics, Inc.
CENTRAL INDEX KEY: 0001806319
IRS NUMBER: 833445958
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-363080
FILM NUMBER: 20721313
BUSINESS ADDRESS:
STREET 1: 15 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-549-8854
MAIL ADDRESS:
STREET 1: 15 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
D
1
primary_doc.xml
X0708
D
LIVE
0001806319
Gracili Therapeutics, Inc.
15 TW ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
NORTH CAROLINA
27709
919-549-8854
DELAWARE
None
None
Corporation
true
2019
John
Taylor
15 TW Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Executive Officer
Director
Atul
Chopra
15 TW Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Executive Officer
Director
Andy
Jordan
15 TW Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-03-09
false
true
false
0
Indefinite
100000
Indefinite
false
1
0
0
0
false
Gracili Therapeutics, Inc.
/s/ John Taylor
John Taylor
Chief Executive Officer
2020-03-17